DocGo Inc. Goodwill, Foreign Currency Translation Gain (Loss)
DocGo Inc. (DCGO) reported Goodwill, Foreign Currency Translation Gain (Loss) of $437.12 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-03-16
- DocGo Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was -$23.16K.
- DocGo Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$146.59K, a 141.05% decline year-over-year.
- DocGo Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-06-30 was $400.21K, a 2507.05% increase year-over-year.
- DocGo Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-03-31 was $206.67K.
- DocGo Inc. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $437.12K.
- DocGo Inc. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$107.38K.
- DocGo Inc. goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$2.67K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$23.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$169.75K derived: sum of 2 quarters · filed 2026-03-16 | $230.46K derived: sum of 3 quarters · filed 2026-03-16 | $437.12K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$146.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $253.62K derived: sum of 2 quarters · filed 2025-11-10 | $460.29K 10-Q · filed 2025-11-10 | $30.60K derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-06-30 | $400.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $606.88K 10-Q · filed 2025-08-07 | $177.18K derived: sum of 3 quarters · filed 2026-03-16 | $534.32K derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-03-31 | $206.67K 10-Q · filed 2025-05-08 | -$223.03K derived: sum of 2 quarters · filed 2026-03-16 | $134.11K derived: sum of 3 quarters · filed 2026-03-16 | $149.46K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-12-31 | -$429.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$72.56K derived: sum of 2 quarters · filed 2026-03-16 | -$57.21K derived: sum of 3 quarters · filed 2026-03-16 | -$107.38K 10-K · filed 2026-03-16 |
| 2024-09-30 | $357.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $372.48K derived: sum of 2 quarters · filed 2024-11-07 | $322.31K 10-Q · filed 2024-11-07 | $267.94K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | $15.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$34.82K 10-Q · filed 2024-08-07 | -$89.19K derived: sum of 3 quarters · filed 2025-02-27 | -$315.73K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | -$50.17K 10-Q · filed 2024-05-08 | -$104.55K derived: sum of 2 quarters · filed 2025-02-27 | -$331.08K derived: sum of 3 quarters · filed 2025-02-27 | |
| 2023-12-31 | -$54.38K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$280.91K derived: sum of 2 quarters · filed 2025-02-27 | -$2.67K 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$226.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $51.70K 10-Q · filed 2023-11-06 | ||
| 2023-06-30 | $278.24K 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |